Literature DB >> 6793519

Polysaccharide of the slime glycolipoprotein of Pseudomonas aeruginosa.

L H Koepp, T Orr, P F Bartell.   

Abstract

The polysaccharide moiety was isolated by mild acid hydrolysis from the slime glycolipoprotein of Pseudomonas aeruginosa strain BI. After gel filtration, the polysaccharide obtained from the Carbohydrate peak fractions was found to be lipid- and protein-free. Analyses indicated that the polysaccharide contained the carbohydrate components of the parent glycolipoprotein. Molecular size of the polysaccharide was estimated by gel filtration as 70,000 to 100,000. The polysaccharide showed no indications of toxicity in mice at doses far in excess of the lethal dose for the parent glycolipoprotein, nor did the mice develop the leukopenia that characteristically follows intraperitoneal injection of glycolipoprotein. The polysaccharide acted as an inhibitor of indirect hemagglutination of glycolipoprotein-coated erythrocytes in the presence of anti-glycolipoprotein serum; however, it was not antigenic itself in rabbits. Coupled with methylated bovine serum albumin, the polysaccharide continued to lack the leukopenic and toxic properties of the parent glycolipoprotein, but the coupled polysaccharide was capable of stimulating indirect hemagglutinating antibody against both the polysaccharide and the glycolipoprotein coating erythrocytes. Moreover, the antibody to the coupled polysaccharide protected mice against challenge with lethal doses of viable P. aeruginosa with the same effectiveness as anti-glycolipoprotein serum.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6793519      PMCID: PMC350780          DOI: 10.1128/iai.33.3.788-794.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response.

Authors:  R J O'Reilly; P Anderson; D L Ingram; G Peter; D H Smith
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

Review 2.  Microbial surfaces in relation to pathogenicity.

Authors:  H Smith
Journal:  Bacteriol Rev       Date:  1977-06

3.  Selective inhibition of phagocytic activity of rabbit alveolar macrophages by cystic fibrosis serum.

Authors:  B Boxerbaum; A Kagumba; L W Matthews
Journal:  Am Rev Respir Dis       Date:  1973-10

4.  The slime of Pseudomonas aeruginosa: biological characterization and possible role in experimental infection.

Authors:  J W Sensakovic; P F Bartell
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

5.  Studies on the bacteriophage 2 receptors of Pseudomonas aeruginosa.

Authors:  F J Castillo; P F Bartell
Journal:  J Virol       Date:  1974-10       Impact factor: 5.103

6.  Biological activity of fragments derived from the extracellular slime glycolipoprotein of Pseudomonas aeruginosa.

Authors:  J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

7.  Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.

Authors:  G B Pier; H F Sidberry; J C Sadoff
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

8.  Pseudomonas bacteremia. Review of 108 cases.

Authors:  M R Flick; L E Cluff
Journal:  Am J Med       Date:  1976-04       Impact factor: 4.965

9.  Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides.

Authors:  J B Robbins; C J Lee; S C Rastogi; G Schiffman; J Henrichsen
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

10.  Slime of Pseudomonas aeruginosa: in vivo production.

Authors:  G Dimitracopoulos; J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

View more
  1 in total

1.  Alginate production by clinical nonmucoid Pseudomonas aeruginosa strains.

Authors:  E D Anastassiou; A C Mintzas; C Kounavis; G Dimitracopoulos
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.